Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Dassault Systèmes SE    DSY   FR0000130650

DASSAULT SYSTÈMES SE

(DSY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Medidata Launches myMedidata LIVE: Patient-Facing Video Visit Capability Built Directly into the Rave EDC Platform

10/14/2020 | 10:00am EST

NEW YORK, October 14, 2020 -- Medidata, a Dassault Systèmes Company, the global leader in creating end-to-end solutions supporting the entire clinical trial process today announced the availability of myMedidata LIVE, a new feature on the myMedidata patient portal. myMedidata LIVE is a web-based, live video conferencing capability connecting patients virtually with their clinical trial study staff. Built on the industry's leading Rave EDC (electronic data capture) platform already in use at more clinical research sites globally than any other system, myMedidata LIVE gives researchers and patients a way to engage in remote site visits within the platform of site and patient-facing technologies they are already using on the study.
myMedidata is Medidata's newly released patient portal solution that provides patients with virtual access to all of their study needs in a single web application. It is built using responsive design principles -- as well as input from Medidata's Patient Insights team, a group of patients and patient advocates -- and made to be accessible from any device with an internet connection. Particularly relevant during the current COVID-19 pandemic when in-person visits might be restricted, myMedidata LIVE video visits between patients and sites can replace scheduled site-based appointments and allow the study team to complete its data entry in Rave while the patients remain engaged offsite through myMedidata.
'The COVID-19 global pandemic represents a pivotal moment for virtual care as healthcare organizations seek ways to triage COVID-19 patients while minimizing exposure between patients and clinicians and continue to see patients fearful of catching COVID-19 if they visit the hospital or their physician's office,' said Lynne A. Dunbrack, group vice president, IDC Health Insights.*
'myMedidata LIVE brings a meaningful capability to the clinical research community as virtualization technologies take on an increasingly important role,' said Anthony Costello, senior vice president of mHealth at Medidata. 'As part of our myMedidata patient portal, patients and sites can rely on myMedidata LIVE as an alternative way to engage when in-person site visits are challenging or impossible.'
The latest version of myMedidata also includes two other important clinical tools, which have been redesigned for virtual use and can now be used through the web with a patient's myMedidata account: myMedidata eConsent and myMedidata eCOA (clinical outcomes assessment). Both tools give sites the ability to maintain a consistent and traceable process, since they are directly integrated with Rave EDC, and use the same advanced, trusted technology previously accessed through the eConsent and eCOA apps. In addition, myMedidata eConsent now provides patients the opportunity to learn about and consent to clinical trials at home or at a remote location, and myMedidata eCOA easily and accurately captures patient outcomes.

Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.
*IDC PlanScape: Virtual Care,' US44610619. May 2020

Disclaimer

Dassault Systèmes SA published this content on 14 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 October 2020 13:59:01 UTC


© Publicnow 2020
All news about DASSAULT SYSTÈMES SE
11/20HEALTHVERITY : and Medidata Announce Strategic Partnership to Advance Real World..
PR
11/19DASSAULT SYSTEMES : A Digital Alliance for “Space” within GAIA-X
PU
11/18DASSAULT SYSTEMES : Updates Multi-year Growth Plan, Targets 2020-2024 Non-IFRS E..
AQ
11/17DASSAULT SYSTEMES : Sees Earnings Gains in Coming Years
DJ
11/17DASSAULT SYSTEMES : Systèmes Updates Multi-year Growth Plan, Targets 2020-2024 N..
GL
11/17DASSAULT SYSTEMES : Systèmes Updates Multi-year Growth Plan, Targets 2020-2024 N..
AQ
11/13DASSAULT SYSTEMES : Medidata and Oxford University Innovation's Clinical Outcome..
AQ
11/10France's OVH partners with Google for European cloud computing push
RE
11/09DASSAULT SYSTÈMES : disclosure of trading in own shares
GL
11/09DASSAULT SYSTEMES : Systèmes will hold its Capital Market Day on November 17th, ..
GL
More news
Financials
Sales 2020 4 455 M 5 280 M 5 280 M
Net income 2020 498 M 591 M 591 M
Net Debt 2020 2 201 M 2 609 M 2 609 M
P/E ratio 2020 81,1x
Yield 2020 0,47%
Capitalization 40 097 M 47 368 M 47 523 M
EV / Sales 2020 9,50x
EV / Sales 2021 8,47x
Nbr of Employees 21 557
Free-Float 49,9%
Chart DASSAULT SYSTÈMES SE
Duration : Period :
Dassault Systèmes SE Technical Analysis Chart | DSY | FR0000130650 | MarketScreener
Technical analysis trends DASSAULT SYSTÈMES SE
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 24
Average target price 156,71 €
Last Close Price 153,80 €
Spread / Highest target 17,7%
Spread / Average Target 1,89%
Spread / Lowest Target -28,5%
EPS Revisions
Managers
NameTitle
Bernard Charlès Vice Chairman & Chief Executive Officer
Dominique Florack President
Charles Edelstenne Chairman
Pascal Daloz Chief Operating & Financial Officer
Laurence Barthès Executive VP, Chief People & Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
DASSAULT SYSTÈMES SE4.95%47 368
MICROSOFT CORPORATION33.41%1 590 653
ZOOM VIDEO COMMUNICATIONS, INC.532.39%125 031
SEA LIMITED355.27%90 450
ATLASSIAN CORPORATION PLC75.38%51 941
SYNOPSYS INC.55.17%33 161